{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T08:42:06Z","timestamp":1789461726209,"version":"build-2803163510"},"reference-count":40,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2022.2530","type":"journal-article","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T11:01:49Z","timestamp":1647428509000},"page":"e222530","source":"Crossref","is-referenced-by-count":150,"title":["Trends in Human Papillomavirus\u2013Associated Cancers, Demographic Characteristics, and Vaccinations in the US, 2001-2017"],"prefix":"10.1001","volume":"5","author":[{"given":"Cheng-I.","family":"Liao","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex Andrea","family":"Francoeur","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Kapp","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle Ann P.","family":"Caesar","sequence":"additional","affiliation":[{"name":"California Pacific\/Palo Alto Medical Foundation\/Sutter Research Institute, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warner K.","family":"Huh","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Alabama Birmingham, Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John K.","family":"Chan","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, California Pacific\/Palo Alto\/Sutter Health Research Institute, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,3,16]]},"reference":[{"issue":"26","key":"zoi220106r1","doi-asserted-by":"publisher","first-page":"661","DOI":"10.15585\/mmwr.mm6526a1","article-title":"Human papillomavirus-associated cancers\u2014United States, 2008-2012.","volume":"65","author":"Viens","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"33","key":"zoi220106r3","doi-asserted-by":"publisher","first-page":"918","DOI":"10.15585\/mmwr.mm6733a2","article-title":"Trends in human papillomavirus-associated cancers\u2014United States, 1999-2015.","volume":"67","author":"Van Dyne","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"zoi220106r4","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv086","article-title":"US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines.","volume":"107","author":"Saraiya","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"zoi220106r5","doi-asserted-by":"publisher","first-page":"880","DOI":"10.7326\/0003-4819-156-12-201206190-00424","article-title":"Screening for cervical cancer: US Preventive Services Task Force recommendation statement.","volume":"156","author":"Moyer","year":"2012","journal-title":"Ann Intern Med"},{"issue":"11","key":"zoi220106r6","first-page":"300","article-title":"Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices.","volume":"64","author":"Petrosky","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"33","key":"zoi220106r7","doi-asserted-by":"publisher","first-page":"724","DOI":"10.15585\/mmwr.mm6833a3","article-title":"Human papillomavirus-attributable cancers\u2014United States, 2012-2016.","volume":"68","author":"Senkomago","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"zoi220106r12","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.ygyno.2021.02.037","article-title":"Racial disparities in high-risk uterine cancer histologic subtypes: a United States Cancer Statistics study.","volume":"161","author":"Abel","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"19","key":"zoi220106r18","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1056\/NEJMoa061741","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions.","volume":"356","author":"FUTURE II Study Group","year":"2007","journal-title":"N Engl J Med"},{"issue":"9686","key":"zoi220106r19","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","article-title":"Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women.","volume":"374","author":"Paavonen","year":"2009","journal-title":"Lancet"},{"issue":"14","key":"zoi220106r20","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","article-title":"HPV vaccination and the risk of invasive cervical cancer.","volume":"383","author":"Lei","year":"2020","journal-title":"N Engl J Med"},{"issue":"10","key":"zoi220106r21","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1002\/ijc.v142.10","article-title":"Vaccination protects against invasive HPV-associated cancers.","volume":"142","author":"Luostarinen","year":"2018","journal-title":"Int J Cancer"},{"issue":"2","key":"zoi220106r22","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.amepre.2018.03.013","article-title":"Cervical cancer incidence in young U.S. females after human papillomavirus vaccine introduction.","volume":"55","author":"Guo","year":"2018","journal-title":"Am J Prev Med"},{"issue":"10","key":"zoi220106r23","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1093\/jnci\/djab080","article-title":"Real-world effectiveness of human papillomavirus vaccination against cervical Cancer.","volume":"113","author":"Kjaer","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"10316","key":"zoi220106r24","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1016\/S0140-6736(21)02178-4","article-title":"The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study.","volume":"398","author":"Falcaro","year":"2021","journal-title":"Lancet"},{"issue":"9","key":"zoi220106r25","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1023\/B:CACO.0000003811.98261.3e","article-title":"Smoking and cervical cancer: pooled analysis of the IARC multi-centric case\u2014control study.","volume":"14","author":"Plummer","year":"2003","journal-title":"Cancer Causes Control"},{"issue":"3","key":"zoi220106r26","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/CEJ.0000000000000164","article-title":"The association between BMI and cervical cancer risk: a meta-analysis.","volume":"25","author":"Poorolajal","year":"2016","journal-title":"Eur J Cancer Prev"},{"issue":"12","key":"zoi220106r27","doi-asserted-by":"publisher","first-page":"415","DOI":"10.15585\/mmwr.mm7012a2","article-title":"Declines in prevalence of human papillomavirus vaccine\u2013type infection among females after introduction of vaccine\u2014United States, 2003-2018.","volume":"70","author":"Rosenblum","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9","key":"zoi220106r28","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1080\/00016480601110170","article-title":"The incidence of tonsillar cancer in Sweden is increasing.","volume":"127","author":"Hammarstedt","year":"2007","journal-title":"Acta Otolaryngol"},{"issue":"12","key":"zoi220106r29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146185","article-title":"Incidence, trends and ethnic differences of oropharyngeal, anal and cervical cancers: Singapore, 1968-2012.","volume":"10","author":"Lam","year":"2015","journal-title":"PLoS One"},{"issue":"12","key":"zoi220106r30","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1002\/ijc.v140.12","article-title":"Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma.","volume":"140","author":"Holzinger","year":"2017","journal-title":"Int J Cancer"},{"issue":"29","key":"zoi220106r31","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1200\/JCO.2015.61.6995","article-title":"Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma.","volume":"33","author":"Gillison","year":"2015","journal-title":"J Clin Oncol"},{"key":"zoi220106r32","article-title":"Long-term impact of HPV vaccination and COVID-19 pandemic on oropharyngeal cancer incidence and burden among men in the USA: A modeling study.","volume":"8","author":"Damgacioglu","year":"2022","journal-title":"Lancet Reg Health Am"},{"key":"zoi220106r33","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.oraloncology.2017.12.008","article-title":"Sensitivity and specificity of oral HPV detection for HPV-positive head and neck cancer.","volume":"77","author":"Gipson","year":"2018","journal-title":"Oral Oncol"},{"issue":"12","key":"zoi220106r34","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1093\/infdis\/jiw063","article-title":"Sex differences in risk factors and natural history of oral human papillomavirus infection.","volume":"213","author":"D\u2019Souza","year":"2016","journal-title":"J Infect Dis"},{"issue":"19","key":"zoi220106r35","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1056\/NEJM199711063371904","article-title":"Sexually transmitted infection as a cause of anal cancer.","volume":"337","author":"Frisch","year":"1997","journal-title":"N Engl J Med"},{"issue":"3","key":"zoi220106r36","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.ajog.2015.10.918","article-title":"Prevalence of anal human papillomavirus infection and anal human papillomavirus\u2013related disorders in women: a systematic review.","volume":"214","author":"Vidulich","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"zoi220106r37","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/S1473-3099(19)30164-1","article-title":"Cervical determinants of anal HPV infection and high-grade anal lesions in women: a collaborative pooled analysis.","volume":"19","author":"Lin","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"zoi220106r38","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1158\/1055-9965.EPI-15-0044","article-title":"Anal cancer incidence in the United States, 1977-2011: distinct patterns by histology and behavior.","volume":"24","author":"Shiels","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"zoi220106r39","doi-asserted-by":"publisher","first-page":"37","DOI":"10.21037\/jgo","article-title":"Racial and gender disparities in the incidence of anal cancer: analysis of the Nationwide Inpatient Sample (NIS).","volume":"10","author":"Cruz","year":"2019","journal-title":"J Gastrointest Oncol"},{"issue":"33","key":"zoi220106r40","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.15585\/mmwr.mm6933a1","article-title":"National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years\u2014United States, 2019.","volume":"69","author":"Elam-Evans","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"zoi220106r2","volume-title":"Cancers Associated with Human Papillomavirus, United States\u20142013\u20132017. USCS Data Brief, no 18","author":"Centers for Disease Control and Prevention","year":"2020"},{"key":"zoi220106r8","unstructured":"Centers for Disease Control and Prevention. US Cancer Statistics Public Use Databases. Accessed January 1, 2021. https:\/\/www.cdc.gov\/cancer\/uscs\/public-use\/index.htm"},{"key":"zoi220106r9","unstructured":"National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database: NPCR and SEER Incidence\u2014US Cancer Statistics 2001-2017 Public Use Research Database, 2019 Submission (2001-2017), United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Accessed July 1, 2021. https:\/\/www.cdc.gov\/cancer\/uscs\/public-use"},{"key":"zoi220106r10","unstructured":"Centers for Disease Control and Prevention. August 10, 2020. Behavioral Risk Factor Surveillance System. Accessed January 1, 2021. https:\/\/www.cdc.gov\/brfss\/"},{"key":"zoi220106r11","unstructured":"Centers for Disease Control and Prevention TeenVaxView. Coverage Data Source. August 24, 2017. Accessed April 1, 2021. https:\/\/www.cdc.gov\/vaccines\/imz-managers\/coverage\/teenvaxview\/data-sources.html"},{"key":"zoi220106r13","unstructured":"Centers for Disease Control and Prevention. Definitions of risk factor\u2013associated cancers. US Cancer Statistics Public Use Databases. Accessed January 1, 2021. https:\/\/www.cdc.gov\/cancer\/uscs\/public-use\/predefined-seer-stat-variables.htm"},{"key":"zoi220106r14","unstructured":"Howlader? N, Noone? AM, Krapcho? M? . SEER Cancer Statistics Review, 1975-2018. National Cancer Institute. April 2021. Accessed May 1, 2021. https:\/\/seer.cancer.gov\/csr\/1975_2018\/"},{"key":"zoi220106r15","unstructured":"National Cancer Institute. Surveillance, Epidemiology, and End Results Program. Race recode changes\u2014SEER Documentation. January 1, 2005. Accessed January 1, 2021. https:\/\/seer.cancer.gov\/seerstat\/variables\/seer\/race_ethnicity\/"},{"key":"zoi220106r16","unstructured":"Centers for Disease Control and Prevention. US Cancer Statistics Public Use Database. Merged summary stage variables. June 8, 2021, June 8. Accessed January 1, 2021. https:\/\/www.cdc.gov\/cancer\/uscs\/public-use\/dictionary\/merged-summary-stage.htm"},{"key":"zoi220106r17","unstructured":"Joinpoint Help System. Number of joinpoints. January 1, 2021. Accessed January 15, 2021. https:\/\/surveillance.cancer.gov\/help\/joinpoint\/setting-parameters\/method-and-parameters-tab\/number-of-joinpoints"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2790165\/liao_2022_oi_220106_1646844127.62105.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T11:02:01Z","timestamp":1647428521000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2790165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,16]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.2530","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,16]]}}}